NO20042846L - Derivater av 5-(pyridin-3-yl)-1-azabicyklo[3.2.1]oktan, fremstilling derav og anvendelse av de samme som terapeutiske midler - Google Patents

Derivater av 5-(pyridin-3-yl)-1-azabicyklo[3.2.1]oktan, fremstilling derav og anvendelse av de samme som terapeutiske midler

Info

Publication number
NO20042846L
NO20042846L NO20042846A NO20042846A NO20042846L NO 20042846 L NO20042846 L NO 20042846L NO 20042846 A NO20042846 A NO 20042846A NO 20042846 A NO20042846 A NO 20042846A NO 20042846 L NO20042846 L NO 20042846L
Authority
NO
Norway
Prior art keywords
azabicyclo
pyridin
octane
derivatives
preparation
Prior art date
Application number
NO20042846A
Other languages
English (en)
Other versions
NO329309B1 (no
Inventor
Frederic Galli
Alistair Lochead
Odile Leclerc
Alain Nedelec
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20042846L publication Critical patent/NO20042846L/no
Publication of NO329309B1 publication Critical patent/NO329309B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20042846A 2002-01-07 2004-07-05 Derivater av 5-(pyridin-3-yl)-1-azabicyklo[3.2.1]oktan, og anvendelse av de samme i medikamenter og terapeutiske preparater. NO329309B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200109A FR2834511B1 (fr) 2002-01-07 2002-01-07 Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
PCT/FR2003/000004 WO2003057697A1 (fr) 2002-01-07 2003-01-03 Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO20042846L true NO20042846L (no) 2004-09-21
NO329309B1 NO329309B1 (no) 2010-09-27

Family

ID=8871176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042846A NO329309B1 (no) 2002-01-07 2004-07-05 Derivater av 5-(pyridin-3-yl)-1-azabicyklo[3.2.1]oktan, og anvendelse av de samme i medikamenter og terapeutiske preparater.

Country Status (35)

Country Link
US (2) US7223750B2 (no)
EP (1) EP1465893B1 (no)
JP (1) JP4402957B2 (no)
KR (1) KR100977332B1 (no)
CN (2) CN1276921C (no)
AR (2) AR038098A1 (no)
AT (1) ATE355290T1 (no)
AU (1) AU2003216777B2 (no)
BR (1) BR0306707A (no)
CA (1) CA2471628C (no)
CO (1) CO5590914A2 (no)
CY (1) CY1106580T1 (no)
DE (1) DE60312123T2 (no)
DK (1) DK1465893T3 (no)
EA (1) EA007793B1 (no)
EC (1) ECSP045176A (no)
ES (1) ES2281631T3 (no)
FR (1) FR2834511B1 (no)
HR (1) HRP20040617B1 (no)
IL (2) IL162524A0 (no)
IS (1) IS2470B (no)
MA (1) MA27165A1 (no)
ME (2) MEP24408A (no)
MX (1) MXPA04006630A (no)
NO (1) NO329309B1 (no)
NZ (1) NZ533793A (no)
PL (1) PL216665B1 (no)
PT (1) PT1465893E (no)
RS (1) RS50921B (no)
SI (1) SI1465893T1 (no)
TN (1) TNSN04120A1 (no)
TW (1) TWI336703B (no)
UA (1) UA77229C2 (no)
WO (1) WO2003057697A1 (no)
ZA (1) ZA200405002B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902007D0 (en) * 1999-01-30 1999-03-17 Thomas Carpentry Services Limi Improvements relating to door frames
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
FR2889701B1 (fr) * 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
FR2889847B1 (fr) 2005-08-18 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
FR2912404B1 (fr) * 2007-02-09 2009-04-10 Sanofi Aventis Sa Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR101925971B1 (ko) 2011-01-28 2018-12-06 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
CA3205816A1 (en) 2017-11-03 2019-05-09 Alcon Inc. Azabicyclo and diazepine derivatives for treating ocular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
AU7474794A (en) 1993-07-22 1995-02-20 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
KR100977332B1 (ko) 2010-08-20
CA2471628C (en) 2011-03-22
DK1465893T3 (da) 2007-06-04
UA77229C2 (uk) 2006-11-15
ES2281631T3 (es) 2007-10-01
PL216665B1 (pl) 2014-04-30
KR20040077705A (ko) 2004-09-06
HK1066547A1 (en) 2005-03-24
US20050020568A1 (en) 2005-01-27
SI1465893T1 (sl) 2007-08-31
DE60312123D1 (de) 2007-04-12
TWI336703B (en) 2011-02-01
US7223750B2 (en) 2007-05-29
PT1465893E (pt) 2007-05-31
CN1612876A (zh) 2005-05-04
EA007793B1 (ru) 2007-02-27
ATE355290T1 (de) 2006-03-15
CA2471628A1 (en) 2003-07-17
US20070185137A1 (en) 2007-08-09
US7585974B2 (en) 2009-09-08
ZA200405002B (en) 2006-05-31
WO2003057697A1 (fr) 2003-07-17
CY1106580T1 (el) 2012-01-25
NZ533793A (en) 2007-01-26
DE60312123T2 (de) 2007-09-13
IS7322A (is) 2004-06-16
AR086573A2 (es) 2014-01-08
RS50921B (sr) 2010-08-31
HRP20040617A2 (en) 2004-10-31
JP2005514422A (ja) 2005-05-19
EP1465893B1 (fr) 2007-02-28
TNSN04120A1 (fr) 2006-06-01
CN1911928A (zh) 2007-02-14
NO329309B1 (no) 2010-09-27
BR0306707A (pt) 2005-02-09
IL162524A (en) 2010-05-17
AU2003216777B2 (en) 2008-10-02
IS2470B (is) 2008-12-15
PL370065A1 (en) 2005-05-16
FR2834511A1 (fr) 2003-07-11
IL162524A0 (en) 2005-11-20
FR2834511B1 (fr) 2004-02-13
CN1276921C (zh) 2006-09-27
TW200305413A (en) 2003-11-01
AR038098A1 (es) 2004-12-29
ECSP045176A (es) 2004-08-27
ME00213B (me) 2011-02-10
EP1465893A1 (fr) 2004-10-13
EA200400770A1 (ru) 2004-12-30
MA27165A1 (fr) 2005-01-03
RS59904A (sr) 2006-10-27
MEP24408A (en) 2010-10-10
HRP20040617B1 (hr) 2012-10-31
AU2003216777A1 (en) 2003-07-24
MXPA04006630A (es) 2004-11-10
JP4402957B2 (ja) 2010-01-20
CO5590914A2 (es) 2005-12-30

Similar Documents

Publication Publication Date Title
IL191960A (en) History of imidazo [5,1– a] pyridine and pharmaceutical preparations containing them
NO20021689L (no) 5-leddede heterocykliske derivater, fremstilling derav og anvendelse som medikamenter
DK1381363T3 (da) Imidazo[1,2-a]pyridinderivater som mGluR5-antagonister
NO20043064L (no) 1-alkyl-1-azoniabisyklo [2.2.2] oktankarbamatderivater og anvendelse av disse som muskarine reseptorantagonister
EE05643B1 (et) Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
AP2004003184A0 (en) Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same and methods for their use.
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
NO20020687L (no) 3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
EE04497B1 (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
NO20043565L (no) Heteroaryl-substituerte 2-pyridinyl- og 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater.
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
NO20016404D0 (no) Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
IS6874A (is) 3,7-díasabísýkló[3.3.0]oktön og notkun þeirra í meðhöndlun á hjartsláttarglöpum
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
IL162524A (en) Derivatives of 5- (pyridin- 3 - yl)-1 - azabicyclo [3.2.1] octane, their preparation and their therapeutic application
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
MXPA03008894A (es) Uso de compuestos de imidazo[1,2-a]-piridin-3-il-amidas e imidazo [1,2-a]-piridin-3-il-aminas sustituidas como medicamentos.
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
NO20054130D0 (no) Kvaterne chelidonin- og alkaloidderivater, fremgangsmate for fremstilling av samme, samt anvendelse av disse for fremstilling av medikamenter

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees